series-a
Stage
3
Investors
About
NeuroDerm develops integrated drug-device combination therapies for central nervous system disorders, specializing in a subcutaneous infusion system delivering levodopa/carbidopa for Parkinson’s disease patients experiencing motor fluctuations.
Explore NeuroDerm's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.